InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.080
+0.010 (0.48%)
Apr 1, 2025, 4:00 PM EDT - Market closed
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $2.51 million as of April 1, 2025. Its market cap has increased by 14.13% in one year.
Market Cap
2.51M
Enterprise Value
-36.52K
1-Year Change
14.13%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $2.51M, a decrease of -90.34%. That is a compound annual growth rate of -41.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 722.79B |
| UnitedHealth Group | 478.32B |
| Johnson & Johnson | 369.30B |
| AbbVie | 364.85B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 228.39B |
| AstraZeneca | 227.81B |
| Merck & Co. | 220.06B |